MK0812
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK0812, covering 2016-08-01 to 2016-08-01. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Effects of MK0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by Magnetic Resonance Imaging (MRI)(0812-003)(COMPLETED) [Phase 2]